Another study published in Advanced Science in 2023 has indicated that tumor-intrinsic Setd2 deficiency enhances recruitment and reprogramming of neutrophils in pancreatic tumors, thereby escaping from immune surveillance via inhibiting the cytotoxicity of CD8+ T cells42. The gene discussed is SETD2; the disease is pancreatic neoplasm.